Maker of natural food seasonings and extracts (bouillon, broth bases) supplied as ingredients to food and foodservice manufacturers.
Maker of natural food seasonings and extracts (bouillon, broth bases) supplied as ingredients to food and foodservice manufacturers.
Sells extracts by weight to food makers and restaurant groups that build them into soups, sauces and ready meals, so revenue follows their volumes. Once an extract is written into a recipe it is slow to change, which makes orders repeat.
In one line: A B2B natural-flavor ingredient maker akin to a smaller Kerry Group/McCormick ingredients .
Moat: narrow (process know-how, customer qualification). Proprietary natural-extraction processes and long-run B2B ingredient qualification with food makers.
Headquarters: Tosu, Japan · Founded: 1966 · Employees: 1,201
Size ARIAKE JAPAN (2815.T) is a Japan Consumer Staples company (Food: Specialty/Candy) with a market value of $1.06B, the 713th largest of 1,370 Japan companies the cockpit tracks. Shares closed at ¥5,320 on 18 Nov 2026.
Performance Over six months the shares fell 3.8%, against -13.3% for the median peer and -1.4% for the Japan market (cap-weighted) — 7th highest of 20 in its peer set.
Growth Revenue grew 5.0% over the last twelve months (peer median +8.5%); the operating margin is 17.3% (peer median 5.9%).
Valuation It trades at 17.6× forward earnings against a peer median of 19.1× (7th cheapest of 18).
Price implies For today's price to make sense, revenue must grow about -6% a year for seven years (Req g). Recent delivered growth is +6%, so the hurdle is -12 pp: the price already allows for a slowdown.
Capital Return on invested capital runs 4.1 points above its cost of capital (5.0% WACC).
Next results Next results expected around 5 Feb 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | ¥68.4B | ¥67.0B | ¥65.4B | ¥60.0B | ¥55.7B |
| Revenue growth | — | +2% | +9% | +8% | — |
| Gross profit | ¥20.9B | ¥20.5B | ¥19.7B | ¥16.7B | ¥16.2B |
| EBITDA | ¥14.2B | ¥14.0B | ¥13.3B | ¥10.7B | ¥10.3B |
| Net income | ¥9.30B | ¥9.46B | ¥8.21B | ¥7.35B | ¥6.39B |
| Free cash flow | n/a | ¥6.74B | ¥11.2B | ¥5.78B | ¥2.58B |
| Capital expenditure | n/a | ¥2.31B | ¥965M | ¥3.05B | ¥3.03B |
| Total debt | ¥7.17M | ¥9.77M | ¥18.0M | ¥26.3M | ¥34.4M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| ARIAKE JAPAN 2815.T | $1.06B | -4% | +5% | 17% | 17.6× | -6.1% |
| Ajinomoto 2802.T | $23.8B | -20% | +10% | 12% | 27.7× | 18.2% |
| McCormick & MKC | $12.5B | -1% | +13% | 17% | 15.1× | 3.2% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 2815.T | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +1.5% | +0.3% | 9th highest of 21 |
| 6-month return | -3.8% | -13.3% | 7th highest of 20 |
| Distance from 52-week high | -13.6% | -30.9% | 5th highest of 21 |
| Revenue growth (TTM) | +5.0% | +8.5% | 9th lowest of 21 |
| Operating margin | 17.3% | 5.9% | 3rd highest of 21 |
| Forward P/E | 17.6× | 19.1× | 7th cheapest of 18 |
| Growth the price implies (Req g, 7 yrs) | -6.1% | 3.8% | 4th least demanding of 12 |
| Growth delivered (Del g) | +6.1% | +10.9% | 5th lowest of 12 |
| Hurdle (Req g minus delivered) | -12.3 pp | -12.5 pp | 6th most demanding of 12 |
| ROIC minus cost of capital | +4.1 pp | -0.5 pp | 6th highest of 20 |
| EV / EBITDA | 8.9× | 8.2× | 7th cheapest of 13 |
| Net debt / EBITDA | -3.1× | 0.9× | 2nd least indebted of 13 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| ARIAKE JAPAN 2815.T | Japan | $1.06B | -4% | +5% | 17% | 17.6× | -6.1% | +6.1% |
| Star Lake Bioscience 600866.SS | China | $1.07B | -24% | -3% | 0% | 37.4× | n/a | n/a |
| ORION 001800.KS | South Korea | $1.02B | -7% | +16% | 15% | n/a | -15.9% | +8.3% |
| Flowers Foods FLO | United States | $1.11B | -27% | +1% | 6% | 8.2× | -6.6% | +3.7% |
| Jiangxi Qiyunshan Food 2797.HK | Hong Kong | $1.00B | n/a | -7% | 17% | n/a | n/a | n/a |
| Snowsky Salt Industry 600929.SS | China | $1.14B | -31% | +32% | 1% | 51.8× | n/a | n/a |
| Jiajia Food 002650.SZ | China | $981M | -27% | -9% | -10% | n/a | 3.8% | -10.0% |
| Italmobiliare ITM.MI | Italy | $1.17B | -13% | +8% | 14% | 14.0× | n/a | n/a |
| Seneca Foods SENEA | United States | $1.18B | +23% | +12% | 8% | 11.8× | -10.4% | +2.5% |
| Lotte 004990.KS | South Korea | $1.21B | -23% | 0% | 1% | 70.0× | n/a | n/a |
| Lotte Wellfood 280360.KS | South Korea | $921M | +15% | +5% | 4% | 10.1× | -1.8% | +15.2% |
| Fufeng 0546.HK | Hong Kong | $1.24B | -36% | +1% | 4% | 7.0× | n/a | n/a |
| T. Hasegawa 4958.T | Japan | $900M | +14% | +8% | 12% | 18.5× | n/a | n/a |
| Guilin Seamild Foods 002956.SZ | China | $900M | -11% | +21% | 11% | 22.1× | 8.2% | +17.0% |
| Nisshin OilliO 2602.T | Japan | $1.25B | +19% | +9% | 4% | 18.6× | n/a | n/a |
| Yantai China Pet Foods 002891.SZ | China | $1.25B | -17% | +21% | 4% | 29.4× | n/a | n/a |
| Chenguang Biotech 300138.SZ | China | $896M | +9% | -4% | 6% | 15.4× | -1.6% | +10.9% |
| Shandong Bailong Chuangyuan Bio-Tech 605016.SS | China | $1.25B | -26% | +19% | 32% | 19.1× | 9.1% | +22.5% |
| Manorama Industries MANORAMA.NS | India | $1.26B | +36% | +60% | 24% | 36.1× | 32.6% | +46.9% |
| Huabao International 0336.HK | Hong Kong | $1.27B | -13% | +13% | 3% | 23.8× | 14.6% | -2.7% |
| Bikaji Foods International BIKAJI.NS | India | $1.28B | -29% | +13% | 9% | 42.4× | 39.9% | +17.5% |